BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 23940000)

  • 1. Efficacy of topical atorvastatin for the treatment of pressure ulcers: a randomized clinical trial.
    Farsaei S; Khalili H; Farboud ES; Karimzadeh I; Beigmohammadi MT
    Pharmacotherapy; 2014 Jan; 34(1):19-27. PubMed ID: 23940000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atorvastatin for the treatment of plaque-type psoriasis.
    Faghihi T; Radfar M; Mehrabian Z; Ehsani AH; Rezaei Hemami M
    Pharmacotherapy; 2011 Nov; 31(11):1045-50. PubMed ID: 22026392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. STAR VaS--Short Term Atorvastatin Regime for Vasculopathic Subjects: a randomized placebo-controlled trial evaluating perioperative atorvastatin therapy in noncardiac surgery.
    Neilipovitz DT; Bryson GL; Taljaard M
    Can J Anaesth; 2012 Jun; 59(6):527-37. PubMed ID: 22528165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atorvastatin has an important acute anti-inflammatory effect in patients with acute coronary syndrome: results of a randomized, double-blind, placebo-controlled study.
    Macin SM; Perna ER; Farías EF; Franciosi V; Cialzeta JR; Brizuela M; Medina F; Tajer C; Doval H; Badaracco R
    Am Heart J; 2005 Mar; 149(3):451-7. PubMed ID: 15864233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multicenter randomized trial of atorvastatin therapy in intensive care patients with severe sepsis.
    Kruger P; Bailey M; Bellomo R; Cooper DJ; Harward M; Higgins A; Howe B; Jones D; Joyce C; Kostner K; McNeil J; Nichol A; Roberts MS; Syres G; Venkatesh B;
    Am J Respir Crit Care Med; 2013 Apr; 187(7):743-50. PubMed ID: 23348980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of atorvastatin/fenofibrate fixed-dose combination tablet compared with atorvastatin and fenofibrate monotherapies in patients with dyslipidemia: a 12-week, multicenter, double-blind, randomized, parallel-group study.
    Davidson MH; Rooney MW; Drucker J; Eugene Griffin H; Oosman S; Beckert M;
    Clin Ther; 2009 Dec; 31(12):2824-38. PubMed ID: 20110022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical phenytoin solution for treating pressure ulcers: a prospective, randomized, double-blind clinical trial.
    Subbanna PK; Margaret Shanti FX; George J; Tharion G; Neelakantan N; Durai S; Chandy SJ; Mathew BS; Suresh R
    Spinal Cord; 2007 Nov; 45(11):739-43. PubMed ID: 17279096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuation of statin therapy in patients with presumed infection: a randomized controlled trial.
    Kruger PS; Harward ML; Jones MA; Joyce CJ; Kostner KM; Roberts MS; Venkatesh B
    Am J Respir Crit Care Med; 2011 Mar; 183(6):774-81. PubMed ID: 20959555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Open-label tofacitinib and double-blind atorvastatin in rheumatoid arthritis patients: a randomised study.
    McInnes IB; Kim HY; Lee SH; Mandel D; Song YW; Connell CA; Luo Z; Brosnan MJ; Zuckerman A; Zwillich SH; Bradley JD
    Ann Rheum Dis; 2014 Jan; 73(1):124-31. PubMed ID: 23482473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early and late benefits of high-dose atorvastatin in patients with acute coronary syndromes: results from the PROVE IT-TIMI 22 trial.
    Ray KK; Cannon CP; McCabe CH; Cairns R; Tonkin AM; Sacks FM; Jackson G; Braunwald E;
    J Am Coll Cardiol; 2005 Oct; 46(8):1405-10. PubMed ID: 16226162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the efficacy and tolerability of pitavastatin and atorvastatin: an 8-week, multicenter, randomized, open-label, dose-titration study in Korean patients with hypercholesterolemia.
    Lee SH; Chung N; Kwan J; Kim DI; Kim WH; Kim CJ; Kim HS; Park SH; Seo HS; Shin DG; Shin YW; Shim WJ; Ahn TH; Ho Yun K; Yoon MH; Cha KS; Choi SW; Han SW; Hyon MS
    Clin Ther; 2007 Nov; 29(11):2365-73. PubMed ID: 18158077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical Nifedipine for the Treatment of Pressure Ulcer: A Randomized, Placebo-Controlled Clinical Trial.
    Zolfagharnezhad H; Khalili H; Mohammadi M; Niknam S; Vatanara A
    Am J Ther; 2021 Jan-Feb 01; 28(1):e41-e51. PubMed ID: 31241491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical pentoxifylline for pressure ulcer treatment: a randomised, double-blind, placebo-controlled clinical trial.
    Najafi E; Ahmadi M; Mohammadi M; Beigmohammadi MT; Heidary Z; Vatanara A; Khalili H
    J Wound Care; 2018 Aug; 27(8):495-502. PubMed ID: 30086256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early statin treatment prior to primary PCI for acute myocardial infarction: REPERATOR, a randomized placebo-controlled pilot trial.
    Post S; Post MC; van den Branden BJ; Eefting FD; Goumans MJ; Stella PR; van Es HW; Wildbergh TX; Rensing BJ; Doevendans PA
    Catheter Cardiovasc Interv; 2012 Nov; 80(5):756-65. PubMed ID: 22419603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative atorvastatin treatment in CABG patients rapidly improves vein graft redox state by inhibition of Rac1 and NADPH-oxidase activity.
    Antoniades C; Bakogiannis C; Tousoulis D; Reilly S; Zhang MH; Paschalis A; Antonopoulos AS; Demosthenous M; Miliou A; Psarros C; Marinou K; Sfyras N; Economopoulos G; Casadei B; Channon KM; Stefanadis C
    Circulation; 2010 Sep; 122(11 Suppl):S66-73. PubMed ID: 20837928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study.
    Pasceri V; Patti G; Nusca A; Pristipino C; Richichi G; Di Sciascio G;
    Circulation; 2004 Aug; 110(6):674-8. PubMed ID: 15277322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atorvastatin decreases computed tomography and S100-assessed brain ischemia after subarachnoid aneurysmal hemorrhage: a comparative study.
    Sanchez-Peña P; Nouet A; Clarençon F; Colonne C; Jean B; Le Jean L; Fonfrede M; Aout M; Vicaut E; Puybasset L
    Crit Care Med; 2012 Feb; 40(2):594-602. PubMed ID: 21926584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immediate administration of atorvastatin decreased the serum MMP-2 level and improved the prognosis for acute heart failure.
    Shirakabe A; Asai K; Hata N; Yokoyama S; Shinada T; Kobayashi N; Tomita K; Tsurumi M; Matsushita M; Mizuno K
    J Cardiol; 2012 May; 59(3):374-82. PubMed ID: 22402418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of atorvastatin pretreatment on infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Hahn JY; Kim HJ; Choi YJ; Jo SH; Kim HJ; Lee S; Ahn KJ; Song YB; Choi JH; Choi SH; Choi YJ; Lee KH; Lee SH; Gwon HC
    Am Heart J; 2011 Dec; 162(6):1026-33. PubMed ID: 22137076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of two-day atorvastatin pretreatment on the incidence of periprocedural myocardial infarction following elective percutaneous coronary intervention: a single-center, prospective, and randomized study.
    Veselka J; Zemánek D; Hájek P; Malý M; Adlová R; Martinkovicová L; Tesar D
    Am J Cardiol; 2009 Sep; 104(5):630-3. PubMed ID: 19699335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.